Alogliptin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 624 publications
Anticancer and apoptotic effect of alogliptin on A549 cancer cell line.
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)
Published: April 09, 2026
Targeted Degradation of Dipeptidyl Peptidase-4 via Proteolysis-Targeting Chimera Technology for Sustained Glycemic Control in Type 2 Diabetes.
Journal: Journal of medicinal chemistry
Published: March 13, 2026
SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.
Journal: JAMA network open
Published: February 23, 2026
Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: January 25, 2026
Repurposing alogliptin for ulcerative colitis: involvement of MicroRNAs, anti-inflammatory, and barrier-restoring mechanisms.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 13, 2025
Noninsulin drugs for type 2 diabetes.
Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2025
Concomitant Use of DPP-4 Inhibitors May Prevent the Development of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Cohort Study.
Journal: Clinical and translational science
Published: October 30, 2025
Sustained alogliptin elicits superior control of glycemia and related complications in diabetic rats: Effects on vital organs functions, biochemistry, and structure.
Journal: European journal of pharmacology
Published: October 22, 2025
Fluorescein-Based Charge-Transfer Fluorimetric Method for Quantification of Gliptin Drugs: Comprehensive Greenness, Blueness, and Sustainability Assessment.
Journal: Luminescence : the journal of biological and chemical luminescence
Published: October 20, 2025
Musculoskeletal adverse events with incretin-based diabetes drugs: a FAERS pharmacovigilance study.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 17, 2025
Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis.
Journal: Cureus
Published: October 14, 2025
Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling.
Journal: The Kaohsiung journal of medical sciences
Published: September 16, 2025
Last Updated: 04/28/2026